Central Alerting System
View Alert


Originator: DHSC & NHS England and Improvement: Supply disruption alert

Issue date: 29-Jul-2021 14:22:47

This alert has been issued to:
  • Care Trusts
  • Mental Health Trusts
  • MHRA (Medicines) Drug Alerts (Various Recipients)
  • Other contacts
  • Specialists Trusts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • NHS Regional Offices
  • Learning Disabilities Trusts
  • Mental Health & Social Care Trusts
  • Ambulance Trusts
  • Social Care Providers (registered with CAS)
  • MHRA (Medicines) Drug Alerts - Non-NHS Recipients
  • Mental Health & Learning Disabilities Trusts
  • Territorial CMOs in Northern Ireland, Scotland & Wales
  • Acute Trusts
  • Community Trusts
  • GP - Locum
  • NHS 111 and Out of hours providers
  • GP Practices
  • DHSC Supply Disruption - Medicines
  • Community Pharmacy
  • Primary Care Networks
  • GP Practices 1

Action category: Action

Title: Tinzaparin sodium (10,000 IU/ml) 3,500 units in 0.35ml and 4,500 units in 0.45ml pre-filled syringes - Supply Disruption

Broadcast content:
Tinzaparin sodium 3,500units in 0.35 ml and 4,500units in 0.45 ml pre-filled syringes will be unavailable between middle of October 2021 and January 2022 (date TBC).

All other presentations of tinzaparin remain unaffected by this supply disruption. 

Organisations who use tinzaparin for both prophylaxis and treatment of venous thromboembolism will need to consider if they wish to switch to an alternative low molecular weight heparin (LMWH) for all indications or just for prophylaxis.

This alert contains further information and action for providers.

Please note that no response is required via the CAS website to this alert.


Additional information: NHS England and NHS Improvement Regional Offices: please cascade this alert to Community Pharmacy.

Alert reference: SDA/2021/008

Attachments:

Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency